A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)
Clinical trial NCT04921969 · COMPLETED
Trial details
- NCT number
- NCT04921969
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-19
- Primary completion
- 2023-05-10
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.